i-MoMCARE: Innovative Mobile Technology for Maternal and Child Health Care in Cambodia-study protocol of a cluster randomized controlled trial.
Asia
Community health workers
Digital health intervention
Implementation research
Low- and middle-income country
Maternal and child health
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
26 Oct 2023
26 Oct 2023
Historique:
received:
14
04
2023
accepted:
10
10
2023
medline:
27
10
2023
pubmed:
26
10
2023
entrez:
26
10
2023
Statut:
epublish
Résumé
The Government of Cambodia established the village health support groups (VHSGs) in 2003 to facilitate primary healthcare activities, including maternal and child health (MCH) services. However, VHSGs face several challenges that hinder them from performing optimally, including a lack of regular structured training and remuneration and limited and inconsistent support and supervision from the health centers (HCs). This implementation research aims to develop, implement, and evaluate a digital health intervention to improve the performance of VHSGs through better support and supervision and increase the MCH service coverage in rural Cambodia. i-MoMCARE, a two-arm cluster randomized controlled trial, will be conducted between 2022 and 2025. Five operational districts (ODs) have been randomized to an intervention arm and the other five ODs to the control arm. The intervention will last for 24 months. Around 200 VHSGs in the intervention arm will be equipped with a mobile application as a job aid and 20 HC staff with a web interface to improve support and supervision of VHSGs. The potential beneficiaries will include pregnant women, mothers, and children under 2 years old. We will measure the outcomes at baseline and endline. The primary outcomes will consist of a composite MCH index constructed from maternal and newborn care indicators, child immunization, and treatment of under-two children. Secondary outcomes will include coverage of selected MCH services. We will conduct the intention-to-treat and per-protocol analyses. We will conduct qualitative interviews with selected beneficiaries and stakeholders to evaluate the intervention's acceptability, feasibility, and scalability. We will also conduct a cost-effective analysis using decision-analytic modeling incorporating a societal perspective that explores different time horizons, intervention effects, and when scaled up to the national level. i-MoMCARE is expected to increase MCH service access and coverage in rural Cambodia. It will contribute to advancing digital health use in primary healthcare interventions, which remains in its infancy in the country. Furthermore, the study findings will be a valuable addition to a growing body of literature on the effectiveness and feasibility of mobile health to improve coverage of MCH services in rural low- and middle-income country settings. ClinicalTrial.gov NCT05639595. Registered on 06 December 2022.
Sections du résumé
BACKGROUND
BACKGROUND
The Government of Cambodia established the village health support groups (VHSGs) in 2003 to facilitate primary healthcare activities, including maternal and child health (MCH) services. However, VHSGs face several challenges that hinder them from performing optimally, including a lack of regular structured training and remuneration and limited and inconsistent support and supervision from the health centers (HCs). This implementation research aims to develop, implement, and evaluate a digital health intervention to improve the performance of VHSGs through better support and supervision and increase the MCH service coverage in rural Cambodia.
METHODS
METHODS
i-MoMCARE, a two-arm cluster randomized controlled trial, will be conducted between 2022 and 2025. Five operational districts (ODs) have been randomized to an intervention arm and the other five ODs to the control arm. The intervention will last for 24 months. Around 200 VHSGs in the intervention arm will be equipped with a mobile application as a job aid and 20 HC staff with a web interface to improve support and supervision of VHSGs. The potential beneficiaries will include pregnant women, mothers, and children under 2 years old. We will measure the outcomes at baseline and endline. The primary outcomes will consist of a composite MCH index constructed from maternal and newborn care indicators, child immunization, and treatment of under-two children. Secondary outcomes will include coverage of selected MCH services. We will conduct the intention-to-treat and per-protocol analyses. We will conduct qualitative interviews with selected beneficiaries and stakeholders to evaluate the intervention's acceptability, feasibility, and scalability. We will also conduct a cost-effective analysis using decision-analytic modeling incorporating a societal perspective that explores different time horizons, intervention effects, and when scaled up to the national level.
DISCUSSION
CONCLUSIONS
i-MoMCARE is expected to increase MCH service access and coverage in rural Cambodia. It will contribute to advancing digital health use in primary healthcare interventions, which remains in its infancy in the country. Furthermore, the study findings will be a valuable addition to a growing body of literature on the effectiveness and feasibility of mobile health to improve coverage of MCH services in rural low- and middle-income country settings.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrial.gov NCT05639595. Registered on 06 December 2022.
Identifiants
pubmed: 37880782
doi: 10.1186/s13063-023-07724-z
pii: 10.1186/s13063-023-07724-z
pmc: PMC10601211
doi:
Banques de données
ClinicalTrials.gov
['NCT05639595']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
692Subventions
Organisme : Bill & Melinda Gates Foundation
ID : INV-022514
Pays : United States
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
BMC Pregnancy Childbirth. 2017 Oct 16;17(1):356
pubmed: 29037179
Lancet. 2012 Mar 31;379(9822):1225-33
pubmed: 22464386
BMC Res Notes. 2019 Apr 24;12(1):236
pubmed: 31014375
Trials. 2017 Jun 9;18(1):270
pubmed: 28599674
JMIR Mhealth Uhealth. 2020 Nov 16;8(11):e22340
pubmed: 33196454
Drug Alcohol Depend. 2016 Nov 01;168:140-146
pubmed: 27664551
Healthcare (Basel). 2020 Jun 26;8(2):
pubmed: 32604756
Int J Equity Health. 2013 Jul 09;12:51
pubmed: 23837577
Hum Resour Health. 2018 Jan 6;16(1):2
pubmed: 29304869
Value Health. 2016 Dec;19(8):921-928
pubmed: 27987641
Reprod Health. 2019 Jul 8;16(1):97
pubmed: 31286989
Ann Transl Med. 2017 Sep;5(17):351
pubmed: 28936445
PLoS One. 2018 Jun 11;13(6):e0198829
pubmed: 29889894
Clin Trials. 2016 Aug;13(4):445-9
pubmed: 27094487
Int J Equity Health. 2019 May 14;18(1):67
pubmed: 31088473
BMC Pregnancy Childbirth. 2021 Jun 2;21(1):410
pubmed: 34078318
Reprod Health. 2016 Jan 05;13:1
pubmed: 26728505
Cost Eff Resour Alloc. 2018 Jun 25;16:25
pubmed: 29983645
Trials. 2018 Apr 19;19(1):235
pubmed: 29673381
JMIR Mhealth Uhealth. 2018 Jun 08;6(6):e140
pubmed: 29884601
Matern Child Health J. 2015 Aug;19(8):1813-24
pubmed: 25652059
Am J Public Health. 2017 Jul;107(7):1078-1086
pubmed: 28520480
PLoS One. 2018 Mar 19;13(3):e0194103
pubmed: 29554118
Biostatistics. 2023 Apr 14;24(2):502-517
pubmed: 34939083
PLoS Med. 2019 Oct 24;16(10):e1002939
pubmed: 31647821
BMC Med Inform Decis Mak. 2018 Nov 12;18(1):95
pubmed: 30419896
Lancet. 2008 Apr 12;371(9620):1259-67
pubmed: 18406860
PLoS One. 2022 Aug 10;17(8):e0272335
pubmed: 35947539
BMJ Open. 2022 Sep 7;12(9):e062028
pubmed: 36691182